Navigation Links
£3.2m ($5.4 million) research project to capture brilliance of butterfly wings
Date:11/9/2009

The brilliance of butterfly wings has inspired a 3.2m, three-year research project that promises to deliver innovation in the fields of security, energy and the environment. The University of Exeter and international technology company QinetiQ have just signed a collaborative contract to develop new technologies based on groundbreaking physical sciences research.

Over the next three years a team of physicists from the University of Exeter and QinetiQ will work together to develop new technologies, based on their discoveries in the field of tailored electromagnetic materials made by studying the wings of butterflies. The team has uncovered the way in which the physical properties of butterflies' wings produce iridescence. By mimicking the unique structures of these wings, they aim to develop new products in the markets of anti-counterfeit technology, radio-frequency identification technology, wi-fi efficiency and security.

The project is funded through the Engineering and Physical Sciences Research Council's (EPSRC) 55m Knowledge Transfer Accounts (KTA), which were established to help translate research into business innovation.

The team aims to launch its first innovation in spring 2010 and will be hosting a number of investor forum events at the University and in London. These evenings are part of the KTA's commitment to develop a lasting relationship and engagement with business angel networks and venture capitalists.

Dr Andrew Shaw of the University of Exeter said: "This project represents a major opportunity for us to use our expertise to benefit society. Our physical sciences research is world-class and this partnership gives us the capacity to take it to the next level by applying it to the development of new ideas. It is also gives us an opportunity to help create a lasting legacy of investor culture in the South West, which will support the development of Exeter's Science Park."

"Butterfly wings create
'/>"/>

Contact: Sarah Hoyle
s.hoyle@exeter.ac.uk
44-013-922-62062
University of Exeter
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology news :

1. GKSS to invest 12 million euros ($15.48 million) in a new observation system for the North Sea
2. Monell Center joins with CAS to host Beijing meeting on taste and smell research
3. Genomic research will enable greener cleanup of military explosive test sites
4. Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers
5. MSU researcher: Obesity significantly cuts odds of successful pregnancy
6. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin
7. First draft of the pig: Researchers sequence swine genome
8. Caltech researchers show efficacy of gene therapy in mouse models of Huntingtons disease
9. ERC provides millions for biodiversity research
10. Columbia University Medical Center announces 2009 Katz Prizes in Cardiovascular Research
11. UT Southwestern researchers use drug-radiation combo to eradicate lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
£3.2m ($5.4 million) research project to capture brilliance of butterfly wings
£3.2m ($5.4 million) research project to capture brilliance of butterfly wings
(Date:11/25/2009)..., police officers and ambulance workers faced a te...omplex. They battled to save people from the colla... fires and evacuated as many people as they could ...ple. And making their jobs even harder was the pro...d their relatives jammed mobile networks with call...
(Date:11/25/2009)...y be just as vital to your health as what you eat,...gical Studies. Their experiments in mice revealed ...enes in the liverthe body,s metabolic clearinghous...e body,s circadian clock as conventional wisdom ha...y of a large number of genes completely independen...
(Date:11/24/2009)... flabby arteries from collapsing have been true li...no longer needed -- once the arteries are strength... had no choice but to leave them in place. , Pro...tment of Biomedical Engineering has developed a ne... where they,re needed, then dissolves. , "Our ne...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 1Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 2Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 3Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 1Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 2Is your environment damaging your health 3F New center aims to find out 47466 1Is your environment damaging your health 3F New center aims to find out 47466 2Is your environment damaging your health 3F New center aims to find out 47466 3
...The cell-signaling molecule Akt is a primary trigg...rface to begin growing vertically beneath the skin... have found. Understanding this key molecular dif...e surface of the skin and melanomas that grow vert...r the development of drugs to treat individuals wi...
...A popular game fish mistaken by scientists for a d...ong the reefs of the Abrolhos region of the South ...l Zootaxa announced the discovery of Lutjanus alex...Lutjanidae family, by researchers Rodrigo Moura of...an of Environmental Defense. The study published i...
...A UCL (University College London) study has found ... not think too hard and instead trust your instinc...urnal Current Biology, shows that, in some cases, ...decisions taken using higher-level cognitive proce...dd one out on a screen covered in over 650 identic...
Other Biology News:Molecular differences between early and advanced melanomas could provide new drug targets 2New species of snapper discovered in Brazil 2Trusting your instincts leads you to the right answer 2Trusting your instincts leads you to the right answer 3
(Date:11/24/2009)...NTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprestigi...,sleadingonlinejobboardandcareerssiteforlifescienc...rsityarenowmembersofthejobboard,joining28othermajo...d, www.biocareercenter.com ,isonlyforpost-graduate...ncecareersitesontheInternet,BioCareerCenteristheon...
(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...hatithasreceivednoticefrom,theNasdaqStockMarkettha...sofNovember30,2009andaForm25-NSEwillbefiledwiththe...CODE,scommonstock,fromlistingonNasdaq,unlessthecom...Panel.Thecompanyhasfiledsuchanappeal,which,willsta...
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
(Date:11/24/2009)...ANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticals...hasallowedthepatentapplicationfor,itsnano-particle...sahighlyefficientapproachtoincorporatepeptidesor,p...eliveryofdrugs,otherwiseadministeredasinjections.N...tomanymacromoleculardrugssuchasinsulin,interferon,...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...ls,Inc. (Nasdaq: CADX ), a biopharmaceutical comp...ializing proprietary product candidates principall... that the company,s,President and CEO Theodore Sch...ew on Tuesday, October 28, 2008 at 9:30am Pacific ...stor Conference at the Hyatt Aventine,La Jolla Hot...
...nounced that it,has provided a GOLD facility for t...) by MTS Health Investors, LLC (MTS). GOLD financi...cilities. Terms of the,transaction were not disclo...e largest and most reputable,DNA testing laborator...dentification testing for the private sector. The ...
...esults (all percentage comparisons are to comparab... Consistent Research Sales Gain: Q3 2008 sales ...3.1% to organic growth of 4.3%. Q3 organic sal...ased sales units was in-line with the 6.9% gain fo...ncy adjusted sales for SAFC decreased by 2.0% ...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIOCOM Investor Conference 2Golub Capital Provides Debt Financing to Support the Acquisition of DNA Diagnostics Center, Inc. by MTS Health Investors, LLC 2Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 2Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 3Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 4Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 5Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 6Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 7Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 8Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 9Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 10Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 11Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 12Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 13Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 14Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 15Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 16Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 17Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 18Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 19Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 20
Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Acc I from Takara Mirus Bio
Microlite 2+ Plate from Thermo Scientific
... low temperature freezers offer a superior sample ...samples with high capacities. Innovative insulatio... excellent warming protection and ensure low energ...fy tracking of sample location and maximize sample...
Biology Products: